Routine evaluation of respiratory function through spirometry after treatment with bronchodilator medicines can help improve diagnosis accuracy for chronic obstructive pulmonary disease (COPD), preventing approximately 39% of overdiagnosis, a new study suggests. Researchers from the University of Kentucky College of Medicine found that using such an assessment…
GlaxoSmithKline (GSK) and Innoviva recently presented positive results of a study showing that Anoro Ellipta is more effective than Stiolto Respimat in symptomatic patients with chronic obstructive pulmonary disease (COPD). The results were presented at the 2017 CHEST Annual Meeting of the American College of Chest Physicians in Toronto, Canada,…
Pooled data from three Phase 3 clinical trials shows that the investigative SUN-101/eFlow product is well-tolerated and improves lung function in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD). Data from the GOLDEN-3, GOLDEN-4, and GOLDEN-5 clinical studies were subject of poster presentations during the American College of…
The American College of Chest Physicians (CHEST) and Sunovion presented their new joint initiative called Delivery Makes a Difference at the CHEST 2016 Annual Meeting Oct. 22-26 in Los Angeles. Delivery Makes a Difference aims to increase awareness about the importance of drug delivery systems for diseases such as chronic obstructive pulmonary…
Get regular updates to your inbox.